Your session is about to expire
← Back to Search
Exercise Training Program for Multiple Sclerosis (TEAAMS Trial)
N/A
Recruiting
Led By Robert W Motl, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in walking scores from baseline, 4-months, and 8-months.
Awards & highlights
Summary
This trial will test if a remotely-delivered, racially-tailored exercise training program can improve walking dysfunction, symptoms, and health-related quality of life for African-Americans with MS who live in rural areas.
Who is the study for?
This trial is for African-American adults with Multiple Sclerosis living in rural areas, who are not very active physically, can use the internet and email, speak English, have been relapse-free for 30 days, and have mild to moderate walking difficulties. It's not for those at high risk of injury or death from intense exercise.
What is being tested?
The study tests a remote exercise program tailored for African-Americans with MS against a control group doing stretching exercises. The goal is to see if the program improves walking ability, symptoms, and quality of life immediately and over four months.
What are the potential side effects?
Since this trial involves an exercise program and stretching routines rather than medication or invasive procedures, side effects may include typical exercise-related issues such as muscle soreness or strain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes in walking scores from baseline, 4-months, and 8-months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in walking scores from baseline, 4-months, and 8-months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Walking Dysfunction
Secondary study objectives
Anxiety
Depressive Symptoms
Disability
+2 moreOther study objectives
Exercise Behavior
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Guidelines for Exercise in Multiple Sclerosis (GEMS)Experimental Treatment1 Intervention
Participants in this condition will receive a 4-month home-based, remotely supported aerobic and resistance exercise program based on the Guidelines for Exercise in Multiple Sclerosis (GEMS).
Group II: FLEX Stretching and Toning ProgramPlacebo Group1 Intervention
Participants in this condition will receive a 4-month home-based, remotely supported stretching program emphasizing flexibility and range of motion as important components of fitness based on Stretching for People with MS: An Illustrated Manual from the National MS Society.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamOTHER
1,621 Previous Clinical Trials
2,290,878 Total Patients Enrolled
38 Trials studying Multiple Sclerosis
45,263 Patients Enrolled for Multiple Sclerosis
Bristol-Myers SquibbIndustry Sponsor
2,678 Previous Clinical Trials
4,125,545 Total Patients Enrolled
14 Trials studying Multiple Sclerosis
21,414 Patients Enrolled for Multiple Sclerosis
University of Illinois at ChicagoLead Sponsor
632 Previous Clinical Trials
1,567,615 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
1,710 Patients Enrolled for Multiple Sclerosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to fill out the study questionnaires.I have been diagnosed with multiple sclerosis (MS).I am 18 years old or older.I have not had a relapse in the last 30 days.I have some difficulty walking but can still move around on my own.
Research Study Groups:
This trial has the following groups:- Group 1: Guidelines for Exercise in Multiple Sclerosis (GEMS)
- Group 2: FLEX Stretching and Toning Program
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT05516537 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger